PRF Technologies (PRFX) Cash & Equivalents (QoQ) (2020 - 2024)
PRF Technologies (PRFX) Cash & Equivalents (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | PRF Technologies | 706,290.59 | -3.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -35.56% |
| Mar 31, 2024 | -46.00% |
| Dec 31, 2023 | 6.16% |
| Sep 30, 2023 | 46.85% |
| Jun 30, 2023 | -36.84% |
| Mar 31, 2023 | 99.00% |
| Dec 31, 2022 | -41.03% |
| Sep 30, 2022 | -49.92% |
| Jun 30, 2022 | -16.31% |
| Mar 31, 2022 | 0.21% |
| Dec 31, 2021 | -9.82% |
| Sep 30, 2021 | 2.99% |
| Jun 30, 2021 | -8.40% |
| Mar 31, 2021 | 23.98% |
| Dec 31, 2020 | -11.54% |
| Sep 30, 2020 | 3,122.36% |
| Jun 30, 2020 | -41.55% |
| Mar 31, 2020 | 0.00% |